These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 28427240)
1. UBE2T knockdown inhibits gastric cancer progression. Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression. Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591 [TBL] [Abstract][Full Text] [Related]
3. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer. Wen M; Kwon Y; Wang Y; Mao JH; Wei G Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072 [TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation. Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022 [TBL] [Abstract][Full Text] [Related]
5. UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation. Deng Y; Chen X; Chen X; Huang C; Zhang Z; Xu Z; Wang X; Wu J; Li L; Song J; Zhou R BMC Cancer; 2024 Sep; 24(1):1158. PubMed ID: 39289660 [TBL] [Abstract][Full Text] [Related]
6. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma. Hao P; Kang B; Li Y; Hao W; Ma F Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis Guo J; Wang M; Wang JP; Wu CX World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276 [TBL] [Abstract][Full Text] [Related]
8. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT. Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of Shen L; Zhao K; Li H; Ning B; Wang W; Liu R; Zhang Y; Zhang A Epigenomics; 2019 Aug; 11(11):1283-1305. PubMed ID: 31355678 [No Abstract] [Full Text] [Related]
10. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Yu Z; Jiang X; Qin L; Deng H; Wang J; Ren W; Li H; Zhao L; Liu H; Yan H; Shi W; Wang Q; Luo C; Long B; Zhou H; Sun H; Jiao Z Oncogene; 2021 Feb; 40(5):1027-1042. PubMed ID: 33323973 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53. Wu M; Li X; Huang W; Chen Y; Wang B; Liu X Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis. Cai F; Xu H; Song S; Wang G; Zhang Y; Qian J; Xu L Curr Protein Pept Sci; 2024; 25(7):577-585. PubMed ID: 38584528 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma. Liu F; Zhu C; Gao P; Zheng S; Li C Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405 [TBL] [Abstract][Full Text] [Related]
14. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway. Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593 [TBL] [Abstract][Full Text] [Related]
16. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A. Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026 [TBL] [Abstract][Full Text] [Related]
17. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer. Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429 [TBL] [Abstract][Full Text] [Related]
18. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription. Li L; Liu J; Huang W Dig Liver Dis; 2022 Jul; 54(7):937-945. PubMed ID: 34583905 [TBL] [Abstract][Full Text] [Related]
19. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711 [TBL] [Abstract][Full Text] [Related]
20. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT. Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]